Works matching IS 13419625 AND DT 2024 AND VI 29 AND IP 4
Results: 13
Prognostic impact of peripheral blood WT1 mRNA dynamics in patients with acute myeloid leukemia treated with venetoclax combination therapy.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 4, p. 481, doi. 10.1007/s10147-024-02480-9
- By:
- Publication type:
- Article
Financial toxicity and patient experience associated with financial burden of molecular-targeted and immune therapies for cancer: an observational study under public health insurance.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 4, p. 417, doi. 10.1007/s10147-024-02479-2
- By:
- Publication type:
- Article
Abnormal activation of RFC3, A YAP1/TEAD downstream target, promotes gastric cancer progression.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 4, p. 442, doi. 10.1007/s10147-024-02478-3
- By:
- Publication type:
- Article
Association of D-dimer level with thrombotic events, bleeding, and mortality in Japanese patients with solid tumors: a Cancer-VTE Registry subanalysis.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 4, p. 407, doi. 10.1007/s10147-024-02475-6
- By:
- Publication type:
- Article
Proteinuria frequency and subsequent renal dysfunction in bevacizumab-treated patients: a single center, retrospective, observational study.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 4, p. 398, doi. 10.1007/s10147-024-02474-7
- By:
- Publication type:
- Article
Trends in gynecologic cancer in Japan: incidence from 1980 to 2019 and mortality from 1981 to 2021.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 4, p. 363, doi. 10.1007/s10147-024-02473-8
- By:
- Publication type:
- Article
Plasma THBS1 as a predictive biomarker for poor prognosis and brain metastasis in patients with HER2-enriched breast cancer.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 4, p. 427, doi. 10.1007/s10147-024-02472-9
- By:
- Publication type:
- Article
First-line dual immune checkpoint inhibitor therapies versus combination therapies comprising immune checkpoint inhibitors and tyrosine kinase inhibitors for advanced renal cell carcinoma: a comparative analysis of the effectiveness using real-world data.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 4, p. 473, doi. 10.1007/s10147-024-02471-w
- By:
- Publication type:
- Article
Immunogenicity after vaccination of COVID-19 vaccines in patients with cancer: a prospective, single center, observational study.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 4, p. 386, doi. 10.1007/s10147-024-02470-x
- By:
- Publication type:
- Article
Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 4, p. 355, doi. 10.1007/s10147-024-02469-4
- By:
- Publication type:
- Article
Hydronephrosis severity as a predictor of postoperative renal function decline following laparoscopic radical nephroureterectomy.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 4, p. 464, doi. 10.1007/s10147-024-02468-5
- By:
- Publication type:
- Article
Effect of cancer cachexia on first-line chemotherapy in patients with advanced pancreatic cancer: a claims database study in Japan.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 4, p. 456, doi. 10.1007/s10147-024-02467-6
- By:
- Publication type:
- Article
Analgesic efficacy and safety of percutaneous thermal ablation plus cementoplasty for painful bone metastases: a systematic review and meta-analysis.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 4, p. 372, doi. 10.1007/s10147-023-02458-z
- By:
- Publication type:
- Article